PUBLISHED MANUSCRIPTS

IDENTIFICATION OF H3N2 NA AND PB1-F2 GENETIC VARIANTS AND THEIR ASSOCIATION WITH DISEASE SYMPTOMS DURING THE 2014-15 INFLUENZA SEASON.

Blumenkrantz D, Mehoke T, Shaw-Saliba K, Powell H, Wohlgemuth N, Liu H, Macias E, Evans J, Lewis M, Medina R, Hardick J, Sauer LM, Dugas A, DuVal A, Lane AP, Gaydos C, Rothman R, Thielen P, Pekosz A.

Virus Evol 2021: http://doi.org/10.1093/ve/veab047.

TRANSKINGDOM INTERACTIONS IMPORTANT FOR THE PATHOGENESIS OF HUMAN VIRUSES.

Nishimoto A*, Wohlgemuth N*, Rosch J, Schultz-Cherry S, Cortez V, Rowe HM. *Contributed Equally.

JID 2021: https://doi.org/10.1093/infdis/jiaa735.

EXUBERANT FIBROBLAST ACTIVITY AFTER SEVERE RESPIRATORY INFECTION COMPROMISES LUNG FUNCTION IN AN ADAMTS-4-DEPENDENT MANNER.

Boyd DF, E. Allen EK, Randolph AG,  Guo XJ, Weng Y, Sanders CJ, Bajracharya R, Lee NK, Guy CS, Vogel P, Guan W, Li Y, Liu X, Novak T, Newhams MM, Fabrizio RP, Wohlgemuth N, Mourani PM, PALISI Pediatric Intensive Care Influenza (PICFLU) Investigators,  Wight TN, Schultz-Cherry S, Cormier SA, Shaw-Saliba K, Pekosz A, Rothman RE, Chen K, Yang Z, Webby RJ, Zhong N, Crawford JC, Thomas PG.

Nature 2020: https://doi.org/10.1038/s41586-020-2877-5.

PRIMARY SWINE RESPIRATORY EPITHELIAL CELL LINES FOR THE EFFICIENT ISOLATION AND PROPAGATION OF INFLUENZA A VIRUSES.

Meliopoulos V, Cherry S, Wohlgemuth N, Honce R, Barnard K, Gauger P, Davis C, Shult P, Parrish C, and Schultz-Cherry S.

Journal of Virology 2020: http://doi.org/10.1128/JVI.01091-20.

CHARACTERIZING EMERGING CANINE H3 INFLUENZA VIRUSES.

Martinez-Sobrido L, Blanco-Lobo P, Rodriguez L, Fitzgerald T, Zhang H, Nguyen P, Anderson CS, Holden-Wiltse J, Bandyopadhyay S, Nogales A, DeDiego ML, Wasik BR, Miller BL, Henry C, Wilson PC, Sangster MY, Treanor JJ, Topham DJ, Byrd-Leotis L, Steinhauer DA, Cummings RD, Luczo JM, Tompkins SM, Sakamoto K, Jones CA, Steel J, Lowen AC, Danzy S, Tao H, Fink AL, Klein SL, Wohlgemuth N, Fenstermacher KJ, El Najjar F, Pekosz A, Sauer L, Lewis MK, Shaw-Saliba K, Rothman RE, Liu ZY, Chen KF, Parrish CR, Voorhees IEH, Kawaoka Y, Neumann G, Chiba S, Fan S, Hatta M, Kong H, Zhong G, Wang G, Uccellini MB, García-Sastre A, Perez DR, Ferreri LM, Herfst S, Richard M, Fouchier R, Burke D, Pattinson D, Smith DJ, Meliopoulos V, Freiden P, Livingston B, Sharp B, Cherry S, Dib JC, Yang G, Russell CJ, Barman S, Webby RJ, Krauss S, Danner A, Woodard K, Peiris M, Perera RAPM, Chan MCW, Govorkova EA, Marathe BM, Pascua PNQ, Smith G, Li YT, Thomas PG, Schultz-Cherry S.

PLoS Pathogens 2020: https://doi.org/10.1371/journal.ppat.1008409.

OBESITY-RELATED MICROENVIRONMENT PROMOTES EMERGENCE OF VIRULENT INFLUENZA VIRUS STRAINS.

Honce R, Karlsson EA, Wohlgemuth N, Estrada LD, Meliopoulos VA, Yao J, Schultz-Cherry S.

Cold Spring Harb Perspect Med 2020: http://doi.org/10.1128/mBio.03341-19.

INFLUENZA IN HIGH-RISK HOSTS-LESSONS LEARNED FROM ANIMAL MODELS

Honce R, Wohlgemuth N, Meliopoulos VA, Short KR, Schultz-Cherry S. Influenza in High-Risk Hosts-Lessons Learned from Animal Models.

Cold Spring Harb Perspect Med 2020: http://doi.org/10.1128/mBio.03341-19.

ASTROVIRUS EVOLUTION AND EMERGENCE.

Wohlgemuth N, Honce R, and Schultz-Cherry S.

Infect, Genet and Evol 2019: https://doi.org/10.1016/j.meegid.2019.01.009.

INFLUENZA A VIRUS M2 PROTEIN APICAL TARGETING IS REQUIRED FOR EFFICIENT VIRUS REPLICATION.

Wohlgemuth N, Lane AP, Pekosz A.

Journal of Virology 2018: https://doi.org/10.1128/JVI.01425-18.

PRODUCTION OF AMPHIREGULIN AND RECOVERY FROM INFLUENZA IS GREATER IN MALES THAN FEMALES.

Vermillion MS, Ursin RL, Kuok DIT, Vom Steeg LG, Wohlgemuth N, Hall OJ, Fink AL, Sasse E, Nelson A, Ndeh R, McGrath-Morrow S, Mitzner W, Chan MCW, Pekosz A, Klein SL.

Biology of Sex Differences 2017: https://doi.org/10.1186/s13293-018-0184-8.

THE M2 PROTEIN OF LIVE, ATTENUATED INFLUENZA VACCINE ENCODES A MUTATION THAT REDUCED VIRUS REPLICATION IN HUMAN NASAL EPITHELIAL CELLS.

Wohlgemuth N*, Ye E*, Fenstermacher K, Liu H, Lane A, Pekosz A. *Contributed Equally.

Vaccine 2017: https://doi.org/10.1016/j.vaccine.2017.10.018.

EVALUATION OF THE INNATE IMMUNE RESPONSES TO INFLUENZA AND LIVE-ATTENUATED INFLUENZA VACCINE INFECTION IN PRIMARY DIFFERENTIATED HUMAN NASAL EPITHELIAL CELLS.

Forero A*, Fenstermacher K*, Wohlgemuth N, Nishida A, Carter V, Smith EA, Peng X, Hayes M, Francis D, Treanor J, Morrison J, Klein SL, Lane A, Katze MG, Pekosz A. *Contributed Equally.
Vaccine 2017: https://doi.org/10.1016/j.vaccine.2017.09.058.

PROGESTERONE-BASED THERAPY PROTECTS AGAINST INFLUENZA BY PROMOTING LUNG REPAIR AND RECOVERY IN FEMALES.

Hall OJ, Limjunyawong N, Vermillion MS, Robinson DP, Wohlgemuth N, Pekosz A, Mitzner W, Klein SL.

​PLoS Pathogens 2016: http://dx.doi.org/10.1371/journal.ppat.1005840.

PREPRINT: THE RIGHT TOOL FOR THE JOB: CORRELATING SARS-COV-2 SPECIFIC ELISA RESPONSES AND SARS-COV-2 PSEUDOTYPED VIRUS NEUTRALIZATION WITH AUTHENTIC VIRUS NEUTRALIZATION IN CONVALESCENT PLASMA.

Wohlgemuth N, Whitt K, Cherry S, Kirkpatrick Roubidoux E, Krammer F, McGargill M, Wolf J, Thomas PG, Whitt MA, Schultz-Cherry S.
medRχiv: https://doi.org/10.1101/2021.04.14.21255399.